article 3 months old

Weekly Top Ten News Stories

Weekly Reports | Dec 14 2018

Our top ten news from 06 December 2018 to 13 December 2018 (ranked according to popularity).

Rudi's View: 'Cheap' Banks, Slowing China, High Volatility
Friday 07 December 2018 – 10:03 AM

Final update on stockbrokers' Conviction Calls and Model Portfolio exposures.

Uranium Week: Canary In The Uranium Mine
Tuesday 11 December 2018 – 11:19 AM

What price is sufficient for curtailed production to start coming back on line? Paladin Energy may have just provided a little hint.

ASX200: 5400 In Sights
Monday 10 December 2018 – 10:30 AM

Craig Parker of Moat Capital believes the ASX200 may be heading towards 5400 but that would provide a buying opportunity.

ResMed Propels Forward
Thursday 06 December 2018 – 10:00 AM

ResMed will acquire Propeller Health, which provides connected care for patients with COPD and asthma. Brokers believe the acquisition puts ResMed at the forefront of this market.

CSL Expands Therapy Pipeline
Thursday 06 December 2018 – 01:14 PM

Revenue growth in core plasma products is still expected as CSL embarks on new classes of therapy in its R&D pipeline.

Material Matters: Outlook, Iron Ore & Copper
Monday 10 December 2018 – 11:02 AM

A glance through the latest expert views and predictions about commodities. Resources and mining outlook; iron ore; and copper.

Australian Broker Call *Extra* Edition – Dec 07, 2018
Friday 07 December 2018 – 11:23 AM

Inaugural Edition of the Broker Call *Extra* Report, featuring additional expert sources on additional ASX-listed stocks.

RESEARCH: Misunderstood Neurology Drug Developer
Thursday 06 December 2018 – 09:18 AM

Pitt Street Research has initiated coverage on Neuren Pharmaceuticals.

The Wrap: Banks, Slots, China And Contractors
Friday 07 December 2018 – 10:39 AM

Weekly Broker Wrap: banks; slot manufacturers; China consumer; contractors; Alliance Minerals; and GR Engineering.

10 APRA Punishes IOOF
Monday 10 December 2018 – 12:31 PM

Australia's prudential regulator has punished IOOF and investors, in turn, now punish the stock. The acquisition of the ANZ wealth business hangs in limbo.

Share on FacebookTweet about this on TwitterShare on LinkedIn

Click to view our Glossary of Financial Terms